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Integrins are involved in various aspects of cell regulation, signaling, and growth and 
have been shown to react to environmental stimuli such as mechanical stress in cardiac 
myocytes. These integrin-mediated reactions may be linked to the upregulation of 
hypertrophic genes that result in cardiac hypertrophy, which is the focus of our lab. CSN 
is a highly conserved complex involved in cell regulation and a critical component to cell 
differentiation. Previous research has shown that the third subunit of the COP9 
signalosome (CSN3) complex binds specifically to ß1D integrin, an isoform that is 
predominant in adult striated muscle. CSN3 is phosphorylated on serine residues 410, 421 
and 423; however the role of these phosphorylation sites remains to be determined. 
Therefore, we hypothesize that phosphorylation at one or a combination of these sites 
results in the physical disassociation of CSN3 from ß1D integrin upon integrin activation. 
To test this hypothesis, CSN3 serine residues 410, 421 and 423 were mutated to either 
Alanine (to prevent phosphorylation) or Aspartic Acid (to mimic phosphorylation). The 
following techniques were utilized in this experiment: polymerase chain reaction (PCR), 
gel electrophoresis and DNA purification. All constructs were confirmed to contain both 
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Heart disease is a broad term referring to any pathology that impedes the normal 
physiological function of the heart. It can be caused by a wide array of factors such as 
environmental, genetics, and natural aging. One common characteristic of preclinical 
heart disease is the hypertrophy of the left ventricle. Similar to other muscles, when the 
heart encounters stress, the cells undergo changes such as an increase in size. Too much 
remodeling can cause structural and functional abnormalities, resulting in heart failure 
and death (Katz AM, 1994; Berenji K. et al., 2005). At a cellular level, pathological 
hypertrophy involves altered gene expression, reorganization of the cell's cytoskeleton 
and cell death (Diwan A et al., 2007). But the question is, how does mechanical stress 
lead to alternations in cellular function and structure? Studies have shown that integrins 
are the link between the cell's cytoskeleton and the extracellular matrix, allowing cells to 
react to mechanical stress (Knoll R, 2003).  
 Integrin is a heterodimer transmembrane protein composed of two chains, the 
alpha and beta subunit. These chains interact with extracellular proteins and the cell's 
cytoskeleton, allowing the cell to react to signals such as mechanical stress. Such 
interactions influence cell differentiation, shape, migration and gene expression (Hunter 
et al. 2008). The ß1 integrin subunit exists in four splice variants in the heart, A-D 
(Baudoin et al. 1996). The most prevalent forms are ß1A and ß1D. Although the two 
isoforms are nearly identical, ß1D is predominantly expressed in mature striated muscle 
and is thus the focus of my research (Belkin A.M. et al. 1997). ß1D is also known to be 
expressed in cardiomyocytes of infarcted myocardium, further indicating the significance  
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of this isoform in heart cells (Sun M. et al. 2003).  
 One protein that is known to bind to ß1D integrin is the third subunit of COP9 
signalosome (CSN) (Hunter et al. 2008). First discovered in Arabidopsis Thaliana, CSN 
is a highly conserved protein made of 8 subunits (Deng et al. 2000; Wei et al. 1998). 
Previous studies have shown that CSN is involved in a number of cellular functions such 
as DNA repair, MAPK signaling, protein phosphorylation and other regulatory activities 
(Bech-Otschi et al. 2002). Recently, it was discovered that the third subunit of CSN, 
CSN3, binds specifically to ß1D integrin in adult heart cells (Hunter et al. 2008). In 
another experiment, CSN regulated gene expression under the stimulus of light (Wei & 
Deng 1992; Chamovitz 2009). Although it is clear that CSN plays a significant role in 
gene expression, its mechanism and pathway in cardiomyocytes are unknown. 
 My project focuses on CSN3's binding interaction with ß1D integrin. A 
hypothetical model for CSN3 in cardiomyocytes will now be described (Figure 1). Upon 
receiving stressful stimuli, ß1D integrin is activated, leading to the disassociation and 
activation of CSN3. Free CSN3 can either translocate into the nucleus, where it activates 
the transcription of hypertrophic genes via a pathway such as AP-1 or affect the 
phosphorylation of NF-kB, which may also translocate to the nucleus to upregulate 
transcription. This experiment involves the mutagenesis of three phosphorylation sites at 
Serine 410, 421, and 423 of CSN3. These serine residues were mutated to either Alanine 
(Ala), to prevent phosphorylation, or to Aspartic Acid (Asp), to mimic phosphorylation. 




The future direction of this experiment will involve using yeast two hybrid to 
determine if the mutated constructs interact with ß1D integrin.  
 
Figure 1. Proposed working model of CSN3 in relation to integrin-mediated cardiac 
hypertrophy.  
 
 Heart disease affects more than one in three American adults and results in over 
2.4 million casualties annually (American Heart Association 2006). An estimated 81.1 
million American adults have one or more types of heart disease, and with no current 
cure, the majority of those people will die due to complications. The results obtained 
from this experiment will provide insight on the binding interaction between ß1D integrin 
and CSN3. If CSN3 is responsible for the activation of hypertrophic genes in 
cardiomyocytes, preventing the disassociation and translocation of CSN3 may be crucial  






Mutagenic Primer Design 
 
Human COP9 signalosome subunit 3 (CSN3) was previously cloned into the pShuttle-
IRES-hrGFP-1 (Mariam Ba, University of Nevada, Reno). The map of pShuttle-IRES-
hrGFP-1 is shown in figure 2. Mutagenic primers were constructed according to the 
recommendations listed in the QuikChange Lightning Multi Site-Directed Mutagenesis 
kit (Stratagene, La Jolla, CA, Catalog #210513-13). Site directed mutagenesis was 
performed on CSN3 at all three potential Serine phosphorylation sites using the following 
primers: Alanine-410 (5’- GTACAAAAGAGTATGGGCGCACAAGAAGATGATTC-
3’), Aspartic acid-410 (5’- 
GTACAAAAGAGTATGGGCGACCAAGAAGATGATTCAGG-3’), Alanine-421,423 
(5’-GGAAACAAACCATCCGCTTATGCTTGAGTCGACGCC-3’), Aspartic acid-
421,423 (5’- GGAAACAAACCATCCGATTATGATTGAGTCGACGCC-3’) and none 











Figure 2. pShuttle-IRES-hrGFP-1. The red lines indicate the exact positioning of the 
CSN3 gene (between the Sal I and Sca I cut sites) in the multiple cloning site. 
 
Polymerase Chain Reaction 
 
The polymerase chain reaction (PCR) was performed according to manufacture 
recommendations (the QuickChange Lightning Multi Site-Directed Mutagenesis kit, 
Stratagene, La Jolla, CA, Catalog #210513-13). Briefly, each mutagenesis reaction was 
composed of 2.5 ul 10x reaction buffer, 140 ng of template DNA (10 kb), 130 ng of each 
primer (one mutagenic and one none mutagenic), 1.5 ul of QuickSolution, 1ul odd NTP 
mix and 1ul enzyme blend. The final volume of each reaction was 25ul. The cycling 
parameters were 95°C for 2 minutes, 30cycles of 95°C for 20 seconds: 55°C for 30 
seconds: 65°C for 5minutes then 65°C for 5minutes. 
Digestion with Dpn I 
One ul of Dpn I (provided by the Mutagenesis kit to digest the methylated parental 
bacterial DNA) was added to the sample at the conclusion of PCR. The sample was then  
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incubated at 37ºC for 5 minutes in a dry incubator. 
Transformation 
The transformation reaction was performed as follow: 5ul of Dpn I digested DNA was 
inoculated into 30 ul of XL10-Gold UltraCompetent cells, the reaction was incubated for 
30 minutes on ice then heat-pulsed at 42°C for 30 seconds. 100 ul of the transformed 
bacteria was plated onto LB Agar plates containing kanamycin (25 ug/ml).  
DNA purification from single colonies (Mini Prep) 
QIAprep Spin Miniprep was used to isolate DNA and purify the. The purity and 
concentration of these samples were determined using a Nanodrop Spectrophotometer.  
Restriction Digest 
Sal I and Sca I were used to digest approximately 500 ng of each CSN3 construct. The 
digests were incubated at 37ºC overnight. 
Gel Electrophoresis 
500ng to 1ug of each construct was run on a 0.8% agarose gel. Two to three ul of 
ethidium bromide was added per 50 ml of gel solution to visualize the DNA bands under 
UV light. Loading dye ( 6x) was added to the cut and uncut constructs as 3x and 2x 
respectively. The gels were run under 110 volts for approximately 80 minutes. A 1kb 
ladder was used as a standard. 
DNA Sequencing and Analysis 
Constructs containing two bands, one at 8.9kb and 1.27kb each, were sent to the Nevada 
Genomics Center for sequencing. The constructs were sequenced with a 653-CSN3 (5’- 
GGAGGGATGATCTATACTGG-3) and a forward pShuttle-IRES (5’-  
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CTCACGGGGATTTCCAAGTC-3’) primer. The results were analyzed using the NCBI 
website and constructs containing the desired mutations were stored in a 1:1 solution of 




I- Mutation from Serine to Alanine at position 410  
1. DNA gel of CSN3-Alanine 410pShuttleIREShrGFP-1 clones 
 
Figure 3. Gel image of CSN3 Serine 410 to Alanine 410. 500ng to 1ug DNA was run 
on a 0.8% agarose gel at 110 volts for 80 minutes. (A) represents the location of the 
pShuttle-IRES-hrGFP-1 vector at 8.9 kb. (B) represents the CSN3 gene insert (1.2kb). 
The DNA ladder (1kb), CSN3 Alanine 410, clone A (uncut), CSN3 Alanine 410, clone A 
(cut), CSN3 Alanine 410, clone B (cut), and CSN3 Alanine 410, clone B (uncut) are 
represented in lanes 1, 2, 3, 4 and 5 respectively. Constructs containing both fragments at 
A and B were sent for sequencing at the Nevada Genomics Center. 
 
2. Sequencing results of CSN3-Alanine 410 pShuttleIREShrGFP-1, clone A 
ref|NM_003653.2| Homo sapiens COP9 constitutive photomorphogenic homolog subunit  
3 (Arabidopsis) (COPS3), mRNA 
Length=1652 
 
GENE ID: 8533 COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 
(Arabidopsis) [Homo sapiens] (Over 10 PubMed links) 
 
 Score = 1205 bits (652),  Expect = 0.0 
 Identities = 654/655 (99%), Gaps = 0/655 (0%) 
 Strand=Plus/Plus 
 
Query  3     ACAGGCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAA  62 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 






Query  63    GTATATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATC  122 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  769   GTATATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATC  828 
 
Query  123   TCAAATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGT  182 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  829   TCAAATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGT  888 
 
Query  183   GTATTCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTT  242 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  889   GTATTCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTT  948 
 
Query  243   CACTCGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAA  302 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  949   CACTCGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAA  1008 
 
Query  303   TATTCAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGT  362 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1009  TATTCAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGT  1068 
 
Query  363   GCAGTTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGA  422 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1069  GCAGTTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGA  1128 
 
Query  423   GATTTTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAA  482 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1129  GATTTTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAA  1188 
 
Query  483   ATATAATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCT  542 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1189  ATATAATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCT  1248 
 
Query  543   GGATGAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAA  602 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1249  GGATGAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAA  1308 
 
Query  603   GAGTATGGGCGCACAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCTTGA  657 
             |||||||||| |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1309  GAGTATGGGCTCACAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCTTGA  1363 
 
Figure 4. Nucleotide sequence of CSN3-Alanine-410 blasted against the human 
CSN3 in the NCBI database. Query represents the CSN3-Alanine-410 (clone A) and 
Sbjct shows the human CSN3 (NM-003653) sequence in the NCBI database. This 
sequence was generated by the CSN3-653 primer. The mutation located at nucleotide 
position 1318 (in red) is confirmed to be the expected mutation. The three nucleotides 
highlighted in yellow (Query line) code for Alanine while the nucleotides highlighted in 
green (Sbjct line) code for Serine. These results indicate a successful mutation from 
Serine to Alanine at position 410 in the CSN3 gene. 
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II. Mutation from Serine 421,423 to Alanine at position 421,423. 
 
1. DNA gel of CSN3-Alanine 421,423 pShuttle-IRES-hrGFP-1 clones 
 
Figure 5. Gel image of CSN3 Serine 421,423 to Alanine 421,423. 500ng to 1ug DNA 
was run on a 0.8% agarose gel at 110 volts for 80 minutes. (A) represents the location of 
the pShuttle-IRES-hrGFP-1 vector at 8.9 kb. (B) represents the CSN3 gene insert (1.2kb). 
The DNA ladder (1kb), CSN3 Alanine 421,423 clone H (uncut), CSN3 Alanine 421,423 
clone H (cut), CSN3 Alanine 421,423 clone I (cut), CSN3 Alanine 421,423 clone J (cut), 
CSN3 Alanine 421,423 clone K (cut), and CSN3 Alanine 421,423 clone L (cut) are 
represented in lanes 1,2, 3, 4, 5, 6, 8 respectively. Constructs containing both fragments at 
A and B were sent for sequencing at the Nevada Genomics Center. 
 
2. Sequencing results of CSN3- Alanine 421,423 pShuttle-IRES-hrGFP-1, clone 
J. 
ref|NM_003653.2| Homo sapiens COP9 constitutive photomorphogenic homolog subunit  
3 (Arabidopsis) (COPS3), mRNA 
Length=1652 
GENE ID: 8533 COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 
(Arabidopsis) [Homo sapiens] (Over 10 PubMed links) 
 
Score = 1011 bits (637),  Expect = 0.0 





Query  1     TACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTATATTTTAGT  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  721   TACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTATATTTTAGT  780 
 
Query  61    GTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAAATTGTGGG  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  781   GTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAAATTGTGGG  840 
 
Query  121   TAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTATTCAACCAA  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  841   TAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTATTCAACCAA  900 
 
Query  181   CAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACTCGCGATAA  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  901   CAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACTCGCGATAA  960 
 
Query  241   CAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATTCAGAGGCT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  961   CAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATTCAGAGGCT  1020 
 
Query  301   AACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAGTTGTCTGG  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1021  AACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAGTTGTCTGG  1080 
 
Query  361   ACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATTTTTGCAAG  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1081  ACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATTTTTGCAAG  1140 
 
Query  421   TATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATATAATAACCC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1141  TATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATATAATAACCC  1200 
 
Query  481   AGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGATGAGCGGCT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1201  AGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGATGAGCGGCT  1260 
 
Query  541   GAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGTATGGGCTC  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1261  GAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGTATGGGCTC  1320 
 
Query  601   ACAAGAAGATGATTCAGGAAACAAACCATCCGCTTATGCTTGA  643 
             |||||||||||||||||||||||||||||||  |||| ||||| 
Sbjct  1321  ACAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCTTGA  1363 
 
Figure 6. Nucleotide sequence of CSN3-Alanine-421, 423 blasted against the human 
CSN3 in the NCBI database. Query represents the CSN3-Alanine-421,423 (clone J) and 
Sbjct shows the human CSN3 (NM-003653) sequence in the NCBI database. This 
sequence was generated by the CSN3-653 primer. The mutations located at nucleotide 
positions 1352, 1353 and 1358 (in red) are confirmed to be the expected mutations. The 
six nucleotides highlighted in yellow (Query line) code for Alanine while the nucleotides 
highlighted in green (Sbjct line) code for Serine. These results indicate a successful 




III. Mutation from Serine 410,421,423 to Alanine at positions 410,421,423. 
 
1. DNA gel of CSN3-Alanine 410,421,423 pShuttle-IRES-hrGFP-1 clones 
 
 
Figure 7. Gel image of CSN3 Serine 410,421,423 to Alanine 410,421,423. 500ng to 
1ug DNA was run on a 0.8% agarose gel at 110 volts for 80 minutes. (A) represents the 
location of the pShuttle-IRES-hrGFP-1 vector at 8.9 kb. (B) represents the CSN3 gene 
insert (1.2kb). The DNA ladder (1kb), CSN3 Alanine 410, 421,423 clone C (uncut), 
CSN3 Alanine 410, 421,423 clone C (cut), CSN3 Alanine 410, 421,423 clone D (cut), 
CSN3 Alanine 410, 421,423 clone E (cut), CSN3 Alanine 410, 421,423 clone F (cut), and 
CSN3 Alanine 410, 421,423 clone G (cut) are represented in lanes 1, 2, 3, 4, 5, 6, 7 
respectively. Constructs containing both fragments at A and B were sent for sequencing at 
the Nevada Genomics Center. 
 
2. Sequencing results of CSN3- Alanine 410, 421,423 pShuttle-IRES-hrGFP-1, 
clone G. 
ref|NM_003653.2|  Homo sapiens COP9 constitutive photomorphogenic homolog subunit  
3 (Arabidopsis) (COPS3), mRNA 
GENE ID: 8533 COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 
(Arabidopsis) [Homo sapiens] (Over 10 PubMed links) 
Length=1652 
 
 Score = 1020 bits (643),  Expect = 0.0 
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Query  1     GCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTAT  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  713   GCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTAT  772 
 
Query  61    ATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAA  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  773   ATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAA  832 
 
Query  121   ATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  833   ATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTAT  892 
 
Query  181   TCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  893   TCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACT  952 
 
Query  241   CGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  953   CGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATT  1012 
 
Query  301   CAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAG  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1013  CAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAG  1072 
 
Query  361   TTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATT  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1073  TTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATT  1132 
 
Query  421   TTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATAT  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1133  TTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATAT  1192 
 
Query  481   AATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGAT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1193  AATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGAT  1252 
 
Query  541   GAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGT  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1253  GAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGT  1312 
 
Query  601   ATGGGCGCACAAGAAGATGATTCAGGAAACAAACCATCCGCTTATGCTTGA  651 
             |||||| ||||||||||||||||||||||||||||||||  |||| ||||| 
Sbjct  1313  ATGGGCTCACAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCTTGA  1363 
 
Figure 8. Nucleotide sequence of CSN3-Alanine-410, 421, 423 blasted against the 
human CSN3 in the NCBI database. Query represents the CSN3-Alanine-410, 421,423 
(clone G) and Sbjct shows the human CSN3 (NM-003653) sequence in the NCBI 
database. This sequence was generated by the CSN3-653 primer. The mutations located 
at nucleotide positions 1318, 1352, 1353 and 1358 (in red) are confirmed to be the 
expected mutations. The nine nucleotides highlighted in yellow (Query line) code for 
Alanine while the nucleotides highlighted in green (Sbjct line) code for Serine. These 




IV. Mutation from Serine 410 to Aspartic Acid at position 410. 
 
1. DNA gel of CSN3-Aspartic Acid 410 pShuttle-IRES-hrGFP-1 clones 
 
Figure 9. Gel image of CSN3 Serine 410 to Aspartic Acid 410. 500ng to 1ug DNA was 
run on a 0.8% agarose gel at 110 volts for 80 minutes. (A) represents the location of the 
pShuttle-IRES-hrGFP-1 vector at 8.9 kb. (B) represents the CSN3 gene insert (1.2kb). 
The DNA ladder (1kb), CSN3 Aspartic Acid 410 clone A (uncut), CSN3 Aspartic Acid 
410 clone A (cut), CSN3 Aspartic Acid 410 clone B (uncut), CSN3 Aspartic Acid 410 
clone B (cut), CSN3 Aspartic Acid 410 clone C (uncut), and CSN3 Aspartic Acid 410 
clone C (cut), and CSN3 Aspartic Acid clone E (cut) are represented in lanes 1, 2, 3, 4, 5, 
6, 7, and 8 respectively. Constructs containing both fragments at A and B were sent for 
sequencing at the Nevada Genomics Center. 
 
2. Sequencing results of CSN3- Aspartic Acid 410 pShuttle-IRES-hrGFP-1, 
clone A. 
ref|NM_003653.2| Homo sapiens COP9 constitutive photomorphogenic homolog subunit  
GENE ID: 8533 COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 
(Arabidopsis) [Homo sapiens] (Over 10 PubMed links) 





Score =  758 bits (654),  Expect = 0.0 
 Identities = 659/663 (99%), Gaps = 1/663 (0%) 
 Strand=Plus/Plus 
 
Query  1     TTTTATG-ACAGGCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCA  59 
             ||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  701   TTTTATGAACAGGCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCA  760 
 
Query  60    TATAAAAAGTATATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAA  119 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  761   TATAAAAAGTATATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAA  820 
 
Query  120   TATACATCTCAAATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTA  179 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  821   TATACATCTCAAATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTA  880 
 
Query  180   GCACAAGTGTATTCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGT  239 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  881   GCACAAGTGTATTCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGT  940 
 
Query  240   GAAACCTTCACTCGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTAT  299 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  941   GAAACCTTCACTCGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTAT  1000 
 
Query  300   AAGAAGAATATTCAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCA  359 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1001  AAGAAGAATATTCAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCA  1060 
 
Query  360   AGTCGTGTGCAGTTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAA  419 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1061  AGTCGTGTGCAGTTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAA  1120 
 
Query  420   GATGGTGAGATTTTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAAC  479 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1121  GATGGTGAGATTTTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAAC  1180 
 
Query  480   CCTGAAAAATATAATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGC  539 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1181  CCTGAAAAATATAATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGC  1240 
 
Query  540   ATTGAGCTGGATGAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTT  599 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1241  ATTGAGCTGGATGAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTT  1300 
 
Query  600   GTACAAAAGAGTATGGGCGACCAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCT  659 
             ||||||||||||||||||   ||||||||||||||||||||||||||||||||||||||| 
Sbjct  1301  GTACAAAAGAGTATGGGCTCACAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCT  1360 
 
Query  660   TGA  662 
             ||| 
Sbjct  1361  TGA  1363 
 
Figure 10. Nucleotide sequence of CSN3-Aspartic Acid-410 blasted against the 
human CSN3 in the NCBI database. Query represents the CSN3-Aspartic Acid-410 
(clone A) and Sbjct shows the human CSN3 (NM-003653) sequence in the NCBI 
database. This sequence was generated by the CSN3-653 primer. The mutations located 
at nucleotide positions 1318, 1319, and 1320 (in red) are confirmed to be the expected 
mutations. The three nucleotides highlighted in yellow (Query line) code for Aspartic 
Acid while the nucleotides highlighted in green (Sbjct line) code for Serine. These results 




V. Mutation from Serine 421, 423 to Aspartic Acid at positions 421,423. 
 
1. DNA gel of CSN3-Aspartic Acid 421,423 pShuttle-IRES-hrGFP-1 clones 
 
Figure 11. Gel image of CSN3 Serine 421,423 to Aspartic Acid 421,423. 500ng to 1ug 
DNA was run on a 0.8% agarose gel at 110 volts for 80 minutes. (A) represents the 
location of the pShuttle-IRES-hrGFP-1 vector at 8.9 kb. (B) represents the CSN3 gene 
insert (1.2kb). The DNA ladder (1kb), CSN3 Aspartic Acid 421, 423 clone I (uncut), 
CSN3 Aspartic Acid 421, 423 clone K (uncut), CSN3 Aspartic Acid 421,423 clone G 
(cut), CSN3 Aspartic Acid 421, 423 clone I (cut), CSN3 Aspartic Acid 421,423 clone J 
(cut), CSN3 Aspartic Acid 421,423 clone K (cut), CSN3 Aspartic Acid 421,423 clone M 
(cut), CSN3 Aspartic Acid 421,423 clone O (cut), and CSN3 Aspartic Acid 421,423 clone 
P (cut) are represented in lanes 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 respectively. Constructs 
containing both fragments at A and B were sent for sequencing at the Nevada Genomics 
Center. 
 
2. Sequencing results of CSN3- Aspartic Acid 421,423 pShuttle-IRES-hrGFP-1, 
clone J. 
ref|NM_003653.2|  Homo sapiens COP9 constitutive photomorphogenic homolog subunit  
3 (Arabidopsis) (COPS3), mRNA 
Length=1652 
GENE ID: 8533 COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 
(Arabidopsis) [Homo sapiens] (Over 10 PubMed links) 
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 Score = 1020 bits (643),  Expect = 0.0 
 Identities = 647/651 (99%), Gaps = 0/651 (0%) 
 Strand=Plus/Plus 
 
Query  1     GCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTAT  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  713   GCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTAT  772 
 
Query  61    ATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAA  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  773   ATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAA  832 
 
Query  121   ATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  833   ATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTAT  892 
 
Query  181   TCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  893   TCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACT  952 
 
Query  241   CGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  953   CGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATT  1012 
 
Query  301   CAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAG  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1013  CAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAG  1072 
 
Query  361   TTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATT  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1073  TTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATT  1132 
 
Query  421   TTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATAT  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1133  TTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATAT  1192 
 
Query  481   AATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGAT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1193  AATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGAT  1252 
 
Query  541   GAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGT  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1253  GAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGT  1312 
 
Query  601   ATGGGCTCACAAGAAGATGATTCAGGAAACAAACCATCCGATTATGATTGA  651 
             |||||||||||||||||||||||||||||||||||||||  ||||  |||| 
Sbjct  1313  ATGGGCTCACAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCTTGA  1363 
 
 
Figure 12. Nucleotide sequence of CSN3-Aspartic Acid-421,423 blasted against the 
human CSN3 in the NCBI database. Query represents the CSN3-Aspartic Acid-
421,423 (clone J) and Sbjct shows the human CSN3 (NM-003653) sequence in the NCBI 
database. This sequence was generated by the CSN3-653 primer. The mutations located 
at nucleotide positions 1352, 1353, 1358, and 1359 (in red) are confirmed to be the 
expected mutations. The three nucleotides highlighted in yellow (Query line) code for 
Aspartic Acid while the nucleotides highlighted in green (Sbjct line) code for Serine. 
These results indicate a successful mutation from Serine to Aspartic Acid at position 
421,423 in the CSN3 gene. 
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VI. Mutation from Serine 410,421,423 to Aspartic Acid at positions 410, 421,423. 
 
1. DNA gel of CSN3-Aspartic Acid 410, 421,423 pShuttle-IRES-hrGFP-1 clones 
 
Figure 13. Gel image of CSN3 Serine 410,421,423 to Aspartic Acid 410, 421,423. 
500ng to 1ug DNA was run on a 0.8% agarose gel at 110 volts for 80 minutes. (A) 
represents the location of the pShuttle-IRES-hrGFP-1 vector at 8.9 kb. (B) represents the 
CSN3 gene insert (1.2kb). The DNA ladder (1kb), CSN3 Aspartic Acid 410, 421, 423 
clone A (cut), CSN3 Aspartic Acid 410, 421, 423 clone B (cut), CSN3 Aspartic Acid 410, 
421, 423 clone C (cut), CSN3 Aspartic Acid 410, 421, 423 clone D (cut), CSN3 Aspartic 
Acid 410, 421, 423 clone E (cut), CSN3 Aspartic Acid 410, 421, 423 clone F (cut), CSN3 
Aspartic Acid 410, 421, 423 clone G (cut), CSN3 Aspartic Acid 410, 421, 423 clone H 
(cut), CSN3 Aspartic Acid 410, 421, 423 clone I (cut), CSN3 Aspartic Acid 410, 421, 423 
clone J (cut), and CSN3 Aspartic Acid 410, 421, 423 clone N (cut) are represented in 
lanes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12, respectively. Constructs containing both 
fragments at A and B were sent for sequencing at the Nevada Genomics Center. 
 
2. Sequencing results of CSN3- Aspartic Acid 410, 421,423 pShuttle-IRES-
hrGFP-1, clone A. 
ref|NM_003653.2|  Homo sapiens COP9 constitutive photomorphogenic homolog subunit  






GENE ID: 8533 COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 
(Arabidopsis) [Homo sapiens] (Over 10 PubMed links) 
 Score = 1011 bits (637),  Expect = 0.0 
 Identities = 644/651 (99%), Gaps = 0/651 (0%) 
 Strand=Plus/Plus 
 
Query  1     GCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTAT  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  713   GCTATAACTACTCCTGCCATGGCGGTCAGTCATATCATGTTGGAATCATATAAAAAGTAT  772 
 
Query  61    ATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAA  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  773   ATTTTAGTGTCTTTGATATTACTTGGCAAAGTACAACAGCTACCAAAATATACATCTCAA  832 
 
Query  121   ATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTAT  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  833   ATTGTGGGTAGATTCATTAAGCCTCTTAGCAATGCATACCACGAGTTAGCACAAGTGTAT  892 
 
Query  181   TCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  893   TCAACCAACAACCCCTCAGAACTCCGAAACCTGGTGAATAAGCACAGTGAAACCTTCACT  952 
 
Query  241   CGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  953   CGCGATAACAACATGGGGCTGGTGAAGCAATGCTTGTCATCTCTTTATAAGAAGAATATT  1012 
 
Query  301   CAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAG  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1013  CAGAGGCTAACAAAGACCTTTTTAACTCTATCATTACAAGATATGGCAAGTCGTGTGCAG  1072 
 
Query  361   TTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATT  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1073  TTGTCTGGACCTCAGGAGGCAGAGAAATACGTTCTGCACATGATAGAAGATGGTGAGATT  1132 
 
Query  421   TTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATAT  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1133  TTTGCAAGTATTAACCAGAAGGACGGTATGGTCAGTTTCCATGATAACCCTGAAAAATAT  1192 
 
Query  481   AATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGAT  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1193  AATAACCCAGCCATGCTTCATAACATTGATCAGGAGATGCTGAAGTGCATTGAGCTGGAT  1252 
 
Query  541   GAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGT  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1253  GAGCGGCTGAAAGCCATGGACCAGGAGATCACAGTGAACCCTCAGTTTGTACAAAAGAGT  1312 
 
Query  601   ATGGGCGACCAAGAAGATGATTCAGGAAACAAACCATCCGATTATGATTGA  651 
             ||||||   ||||||||||||||||||||||||||||||  ||||  |||| 
Sbjct  1313  ATGGGCTCACAAGAAGATGATTCAGGAAACAAACCATCCAGTTATTCTTGA  1363 
 
Figure 14. Nucleotide sequence of CSN3-Aspartic Acid-410, 421,423 blasted against 
the human CSN3 in the NCBI database. Query represents the CSN3-Aspartic Acid-
410,421,423 (clone A) and Sbjct shows the human CSN3 (NM-003653) sequence in the 
NCBI database. This sequence was generated by the CSN3-653 primer. The mutations 
located at nucleotide positions 1318, 1319, 1320, 1352, 1353, 1358, and 1359  (in red) 
are confirmed to be the expected mutations. The nine nucleotides highlighted in yellow 
(Query line) code for Aspartic Acid while the nucleotides highlighted in green (Sbjct line) 
code for Serine. These results indicate a successful mutation from Serine to Aspartic Acid 
at positions 410,421, and 423 in the CSN3 gene. 
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VII. Compilation of CSN3 Mutagenic Constructs 
 
1. DNA gel of CSN3 Final Constructs for Alanine and Aspartic Acid 410, 
421,423 and 410,421,423 
 
Figure 15. Gel image of CSN3 Maxiprep Constructs. 500ng of DNA was run on a 
0.8% agarose gel at 110 volts for 80 minutes. (A) represents the location of the pShuttle-
IRES-hrGFP-1 vector at 8.9 kb. (B) represents the CSN3 gene insert (1.2kb). In row one, 
the DNA ladder (1kb), CSN3 Template (cut), CSN3 Template (uncut), CSN3 Alanine 410 
(cut), CSN3 Alanine 410 (uncut), CSN3 Alanine 421, 423 (cut), CSN3 Alanine 421,423 
(uncut), CSN3 Alanine 410, 421,423 (cut), and CSN3 Alanine 410,421,423 (uncut) are 
represented in lanes 1, 2, 3, 4, 5, 6, 7, 8 and 9 respectively. In row two, the DNA ladder 
(1kb), CSN3 Template (cut), CSN3 Template (uncut), CSN3 Aspartic Acid 410 (cut), 
CSN3 Aspartic Acid 410 (uncut), CSN3 Aspartic Acid 421, 423 (cut), CSN3 Aspartic 
Acid 421,423 (uncut), CSN3 Aspartic Acid 410, 421,423 (cut), and CSN3 Aspartic Acid 





2. Multiple Sequence Alignment for CSN3 Constructs 
 
Figure 16. CLUSTAL 2.1 multiple sequence alignment of CSN3 constructs. The 
sequence shown here is from nucleotides 1316 to 1363 (15 amino-acids) of the human 
CSN3 sequence (NM-003653). The stars indicate sequence identity and the gaps 
represent mismatches at amino acid residues 410, 421 and 423. 
 
Gel Analysis 
The restriction digest of each construct with Sal I and Sca I should result in the 
appearance of two bands, one the size of 8.9kb (pShuttle-IRES-hrGFP 1) and the other 
with the size of 1.27kb (CSN3). CSN3 was inserted into the multiple cloning site of 
pShuttle-IRES-hrGFP 1 prior to this experiment between recognized cut sites for Sal I 
and Sca I (Figure 2). These two bands are clearly visible in all gels and at the correct 
locations. Only the constructs that had these two bands present were sequenced. 
DNA Sequencing Analysis 
All DNA Sequencing was performed at  the Nevada Genomics Center. The trimmed 
sequence of each result was blasted against the human CSN3 in the NCBI database (NM-
003653). Expected mutations are indicated by a mismatch between the query and the 
subject sequences. These mutations resulted in a change from serine to Alanine or to 
Aspartic acid at position 410(fig.4 and fig. 10), 421-423 (fig. 6 and fig. 12) or 410-421-
423 (fig. 8 and fig 14).  Furthermore, although two primers (forward and CSN3 653)  
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were used, only the CSN3-653 primer results are shown. All good constructs did not 
contain any mutations or abnormalities in their forward sequences. 
Discussion: 
 The goal of this experiment was to generate mutagenic constructs of Homo sapien 
CSN3 containing the following mutations: Serine 410, Serine 421,423 and Serine 
410,421,423 to either Aspartic Acid or Alanine. These three serine sites in CSN3 are 
known to be phosphorylated but the effect of phosphorylation is currently unknown. As 
hypothesized, these sites may be crucial to the activation and disassociation of CSN3 
from ß1D Integrin, and thus the focus of this project. 
 The first step of this project was to use mutagenic primers containing the desired 
mutations in a Polymerase Chain Reaction. The first attempt at doing PCR resulted in 
low efficiency as determined by the small number of bacterial colonies on the agar plate. 
The QuickChange protocol was then changed to increasing the amount of template DNA 
and the primers in the reaction as stated in the methods. This resulted in a nearly tenfold 
increase of colonies for the majority of the constructs. 
 As shown in the gel and sequencing results, the transformation of the mutagenic 
PCR products was a success. Each construct was verified to contain the correct mutations 
and the pShuttle-IRES-hrGFP-1 vector. Good constructs were then stored in a glycerol 
solution(1:1) for future use. The next step of this project will include a yeast-two hybrid 
technique in order  to test whether the CSN3 mutants interact with ß1D Integrin . The 
interaction between  CSN3  mutants  and b1D integrin will be confirmed in mammalian 
cells using adenoviruses.  
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Heart disease is a leading killer of adults in the western world. As integrins have 
already been implicated in having a significant role in cellular adaptation and 
communication, it is critical to understand the mechanisms and pathways associated. 
Cardiac hypertrophy is certainly not the only form of heart disease, but it is definitely an 
important precursor and indicator of the severe complications to come. Discovering the 
mechanisms by which integrins mediate cardiac hypertrophy is of great interest to Dr. 
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Table 1. NanoDrop DNA Concentration and Purity Analysis. 2 ul of sample was 
analyzed by a Nanodrop Spectrophotometer. 
 
DNA Concentration and Purity Analysis 
Date Sample ng/μl A260 A280 260/280 260/230 
       
9/17/2010       
 Ala 410b 54.26 1.085 0.543 2 2.16 
 Ala 410c 26.12 0.522 0.269 1.94 2.15 
       
10/4/2010       
 Ala 410 A1 250.92 5.018 2.601 1.93 2.33 
 Ala 410 A2 310.14 6.203 3.223 1.92 2.33 
 Ala 410 A3 101.5 2.03 1.036 1.96 2.03 
 Ala 410 A4 105.32 2.106 1.092 1.93 2.41 
 Ala 410 A5 222.05 4.441 2.282 1.95 2.37 
 Ala 410 B1 242.41 4.848 2.511 1.93 2.36 
 Ala 410 B2 68.39 1.368 0.659 2.08 2.62 
 Ala 410 B3 232.47 4.649 2.419 1.92 2.37 
 Ala 410 B4 77.94 1.559 0.805 1.94 2.42 
 Ala 410 B5 279.26 5.585 2.89 1.93 2.37 
       
11/10/2010       
 Ala 410 664C1 95.85 1.917 1.024 1.87 2.15 
 Ala 410 664C2 75.28 1.506 0.794 1.9 2.18 
 CSN3 Temp 664C1 91.96 1.839 0.982 1.87 2.21 
 CSN3 Temp 664C2 113.23 2.265 1.211 1.87 2.22 
 CSN3 Temp 664C3 93.86 1.877 1.007 1.86 2.14 
 CSN3 Temp 664C4 98.92 1.978 1.069 1.85 2.22 
 CSN3 Temp 664C5 78.16 1.563 0.834 1.87 2.22 
       
11/30/2010       
 CSN3-664C 600.42 12.008 6.657 1.8 2.22 
 Ala 410 664C 737.12 14.742 8.01 1.84 2.25 
       
Date Sample ng/μl A260 A280 260/280 260/230 
       







Asp 410 A 124.55 2.491 1.322 1.88 2.23 
 Asp 410 B 154.69 3.094 1.635 1.89 2.21 
 Asp 410 C 187.75 3.755 1.997 1.88 2.26 
 Asp 410 D 56.69 1.134 0.589 1.92 2.08 
 Asp 410 E 72.29 1.446 0.766 1.89 2.2 
       
1/20/2011       
 Asp 410 maxi 79.42 1.588 0.919 1.73 2.39 
 Ala 421,423 A 61.52 1.23 0.682 1.8 2.15 
 Ala 421,423 B 60.16 1.203 0.685 1.76 2.07 
 Ala 421,423 C 46.49 0.93 0.52 1.79 2.19 
 Ala 410, 421,423 A 71.44 1.429 0.794 1.8 2.17 
 Ala 410, 421,423 B 30.62 0.612 0.377 1.62 2.1 
 Ala 410, 421,423 C 57.81 1.156 0.633 1.83 2.11 
       
1/24/2011       
 Ala 421,423 A 165.67 3.313 1.731 1.91 2.3 
 Ala 421,423 D 65.7 1.314 0.677 1.94 2.24 
 Ala 421,423 E 192.88 3.858 2.018 1.91 2.28 
 Ala 421,423 F 137.03 2.741 1.427 1.92 2.3 
 Ala 421,423 G 197.1 3.942 2.053 1.92 2.31 
 Ala 410, 421,423 C 155.77 3.115 1.622 1.92 2.29 
 Ala 410, 421,423 D 131.13 2.623 1.366 1.92 2.29 
 Ala 410, 421,423 E 155.45 3.109 1.623 1.92 2.26 
 Ala 410, 421,423 F 180.18 3.604 1.881 1.92 2.27 
 Ala 410, 421,423 G 209.3 4.186 2.192 1.91 2.3 
       
02/01/11       
 Ala 410,421,423 H 43.18 0.863 0.44 1.94 2.1 
 Ala 410,421,423 J 11.73 0.235 0.136 1.72 1.83 
 Ala 421,423 H 157.26 3.145 1.67 1.88 2.19 
 Ala 421,423 I 158.76 3.18 1.67 1.9 2.26 
 Ala 421,423 J 178.36 3.57 1.9 1.88 2.08 
 Ala 421,423 K 45.1 0.902 0.474 1.9 2.16 
 Ala 421,423 L 166.06 3.321 1.778 1.87 2.2 
       
02/07/11       
 CSN3 temp purified maxi 126.9 2.54 1.37 1.86 2.29 
 Asp 410C maxi 575.14 11.5 6.16 1.87 2.29 
 
       
2/10/2011       
 Asp 421,423 A 73.66 1.47 0.79 1.87 2.27 
 Asp 421,423 B 24.95 0.5 0.269 1.86 2.33 
 Asp 421,423 C 49.38 0.99 0.53 1.88 2.35 
 Asp 421,423 D 53.54 1.07 0.56 1.92 2.31 
 Asp 421,423 E 37.67 0.753 0.398 1.89 2.28 
 Asp 421,423 F 53.12 1.06 0.56 1.89 2.38 
       
2/14/2011       
 Asp 421,423 B 140.7 2.81 1.52 1.85 2.08 
 Asp 421,423 C 225.4 4.51 2.42 1.86 2.22 
 Asp 421,423 D 146.78 2.94 1.57 1.87 2.15 
 Asp 421,423 E 127.04 2.54 1.37 1.86 2.12 
       
2/25/2011       
 Asp 421,423 G 41.01 0.82 0.093 8.77 2.84 
 Asp 421,423 H -30.38 -0.61 -0.62 0.98 2.11 
 Asp 421,423 I 129.99 2.6 0.996 2.61 2.65 
 Asp 421,423 J 76.08 1.52 0.52 2.96 2.54 
 Asp 421,423 K 113.06 2.26 0.84 2.7 2.35 
 Asp 421,423 L -10.42 -0.21 -0.31 0.68 1.58 
 Asp 421,423 M 56.92 1.14 0.24 4.79 2.39 
 Asp 421,423 N 11.98 0.24 -0.22 -1.07 4.36 
 Asp 421,423 O 162.42 3.25 1.33 2.45 2.4 
 Asp 421,423 P 99.49 1.99 0.68 2.92 2.4 
       
3/2/2011       
 Asp 421, 423 G 129.86 2.6 1.39 1.86 2.16 
 Asp 421,423 H 59.77 1.2 0.64 1.86 1.77 
 Asp 421,423 I 129.22 2.58 1.38 1.87 2.2 
 Asp 421,423 J 141.47 2.83 1.5 1.88 2.13 
 Asp 421,423 L 34.41 0.69 0.37 1.88 1.88 
 Asp 421,423 M 98.37 1.97 1.06 1.86 1.89 
 Asp 421,423 N 78.85 1.58 0.84 1.88 2.03 
 Asp 421,423 P 115.69 2.31 1.24 1.87 2.12 
       
3/8/2011       
 Ala 421,423 maxiA 68.61 1.37 0.76 1.8 2.24 
 Ala 421,423 maxiB 273.42 5.47 2.94 1.86 2.12 
       
3/11/2011       
 
 Asp 410,421,423 A 201.98 4.04 2.14 1.88 2.27 
 Asp 410,421,423 C 152.45 3.05 1.6 1.9 2.3 
 Asp 410,421,423 D 188.81 3.776 1.99 1.89 2.32 
 Asp 410,421,423 E 166.09 3.322 1.77 1.88 2.28 
 Asp 410,421,423 G 157.48 3.15 1.68 1.87 2.24 
 Asp 410,421,423 I 148.85 2.98 1.59 1.88 2.28 
 Asp 410,421,423 J 152.33 3.05 1.62 1.89 2.29 
       
3/23/2011       
 Ala 421,423 maxiA 63.19 1.26 0.69 1.81 2.31 
 Ala 421,423 maxiB 317.62 6.35 3.43 1.85 2.27 
 Ala 410,421,423maxiA 254.52 5.09 2.86 1.78 2.28 
 Ala 410,421,423maxiB 423.45 8.47 4.62 1.83 2.22 
       
3/28/2011       
 Asp 410,421,423 maxi 473.17 9.46 5.11 1.85 2.28 
 Asp 421,423 maxi 75.42 1.5 0.86 1.76 2.6 
 
List of Reagents and Equipment: 
GenePure LE Agarose 500g, E-3120-500, ISC BIO EXPRESS 
Luria Broth Base, Miller, L1900-IKG, SIGMA, Batch #: 108K0128 
Kanamycin, Monosulfate, Fisher Biotech, BP906-5 
Maxi Prep: Endo Free Plasmid Maxi Kit, Catalog #: 12362 
Mini Prep: QIAprep Spin Miniprep Kit, Catalog #: 27104 
Table top centrifuge: Sorvall Biofuge Pico, Beckman Coulter, Avanti J25 Centrifuge 
PCR Machine: Gradient Cycler, Gradient Engine, MJ Research PTC-200 Peltier Thermal 
Cycler 
42ºC dry heater: Fisher Scientific, Dry Bath Incubator 
37ºC plate incubator: Fisher Scientific, Isotemp Incubator 




Media and plate preparation: 
LB media: Add 15.5 g/L LB, add desired deionized water volume, autoclave at 121°C for 
1 hour 
NZY+ Broth: Instructions on how to create this are located in the mutagenesis kit  
Antibiotic LB Agar plates: Instructions on how to create this are located in the 
mutagenesis kit. The desired concentration of kanamycin was created then filter sterilized 
before use. 
Abbreviations 
CSN: COP9 signalosome 
CSN3: Third subunit of CSN 
PCR: Polymerase chain reaction 
Ala: Alanine 
Asp: Aspartic Acid 
 
 
